Clinical Trial Update: Women's Ischemia Syndrome Evaluation (WISE) [Phase 3]

View source ↗

Summary

Clinical trial update indicating the Phase 3 Women's Ischemia Syndrome Evaluation (WISE) study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Coronary Artery Disease
• Ischemic Heart Disease
• Myocardial Ischemia

Snippet

Sponsor: University of Pittsburgh | Conditions: Angina Pectoris, Cardiovascular Diseases | Phase 3 | Status: COMPLETED